Anne L. Brunkan

679 total citations
8 papers, 546 citations indexed

About

Anne L. Brunkan is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Anne L. Brunkan has authored 8 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 5 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Anne L. Brunkan's work include Alzheimer's disease research and treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Cellular transport and secretion (3 papers). Anne L. Brunkan is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Cellular transport and secretion (3 papers). Anne L. Brunkan collaborates with scholars based in United States and United Kingdom. Anne L. Brunkan's co-authors include Alison Goate, Emily Walker, Maribel Martínez, Silva Hečimović, Jun Wang, Bart De Strooper, Huw D. Lewis, Meera Saxena, Raphael Kopan and Min Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neurochemistry and Neurobiology of Disease.

In The Last Decade

Anne L. Brunkan

8 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne L. Brunkan United States 7 432 302 165 94 76 8 546
Yu Tanimura Japan 6 474 1.1× 285 0.9× 162 1.0× 66 0.7× 82 1.1× 7 548
Monique Nicoll United States 3 481 1.1× 412 1.4× 160 1.0× 107 1.1× 147 1.9× 4 740
N. Ramakrishna United States 7 565 1.3× 408 1.4× 110 0.7× 99 1.1× 61 0.8× 10 626
Daniela Kaden Germany 11 571 1.3× 433 1.4× 125 0.8× 86 0.9× 120 1.6× 12 742
Bernhard M. Kohli Switzerland 6 393 0.9× 310 1.0× 91 0.6× 127 1.4× 86 1.1× 6 519
Lauren Herl United States 10 540 1.3× 346 1.1× 191 1.2× 118 1.3× 107 1.4× 10 747
Klaus Mendla Germany 14 432 1.0× 462 1.5× 165 1.0× 183 1.9× 105 1.4× 20 750
Chris De Jonghe Belgium 7 318 0.7× 244 0.8× 103 0.6× 68 0.7× 43 0.6× 9 412
Manasi Benurwar United Kingdom 9 505 1.2× 347 1.1× 170 1.0× 107 1.1× 76 1.0× 9 753
Inga Pinnix United States 9 360 0.8× 232 0.8× 127 0.8× 74 0.8× 85 1.1× 10 467

Countries citing papers authored by Anne L. Brunkan

Since Specialization
Citations

This map shows the geographic impact of Anne L. Brunkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne L. Brunkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne L. Brunkan more than expected).

Fields of papers citing papers by Anne L. Brunkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne L. Brunkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne L. Brunkan. The network helps show where Anne L. Brunkan may publish in the future.

Co-authorship network of co-authors of Anne L. Brunkan

This figure shows the co-authorship network connecting the top 25 collaborators of Anne L. Brunkan. A scholar is included among the top collaborators of Anne L. Brunkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne L. Brunkan. Anne L. Brunkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Brunkan, Anne L., Maribel Martínez, Emily Walker, & Alison Goate. (2005). Presenilin endoproteolysis is an intramolecular cleavage. Molecular and Cellular Neuroscience. 29(1). 65–73. 27 indexed citations
2.
Brunkan, Anne L., et al.. (2005). A domain at the C‐terminus of PS1 is required for presenilinase and γ‐secretase activities. Journal of Neurochemistry. 92(5). 1158–1169. 5 indexed citations
3.
Brunkan, Anne L. & Alison Goate. (2005). Presenilin function and γ‐secretase activity. Journal of Neurochemistry. 93(4). 769–792. 111 indexed citations
4.
Brunkan, Anne L., María Martínez, Emily Walker, et al.. (2005). Two domains within the first putative transmembrane domain of presenilin 1 differentially influence presenilinase and γ‐secretase activity. Journal of Neurochemistry. 94(5). 1315–1328. 22 indexed citations
5.
Walker, Emily, Maribel Martínez, Anne L. Brunkan, & Alison Goate. (2004). Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Aβ 42/40 ratios. Journal of Neurochemistry. 92(2). 294–301. 132 indexed citations
6.
Wang, Jun, Anne L. Brunkan, Silva Hečimović, Emily Walker, & Alison Goate. (2004). Conserved “PAL” sequence in presenilins is essential for γ-secretase activity, but not required for formation or stabilization of γ-secretase complexes. Neurobiology of Disease. 15(3). 654–666. 57 indexed citations
7.
Schroeter, Eric H., Ma. Xenia G. Ilagan, Anne L. Brunkan, et al.. (2003). A presenilin dimer at the core of the γ-secretase enzyme: Insights from parallel analysis of Notch 1 and APP proteolysis. Proceedings of the National Academy of Sciences. 100(22). 13075–13080. 166 indexed citations
8.
Zhou, Yan, Wanjiang Zhang, Rachael Easton, et al.. (2002). Presenilin-1 Protects against Neuronal Apoptosis Caused by Its Interacting Protein PAG. Neurobiology of Disease. 9(2). 126–138. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026